Webinar: A new technology to evaluate cardiac contractility on high throughput level

FLEXcyte 96 Technology

Contractility measurements on human iPSC-derived cardiac myocytes on a 96-well CellDrum by innoVitro

Presentation video of the winners of the AC² start-up competition

Founder profile NUK 2018

Winner of the concept phase of the Science4Life Venture Cup 2018

"We were very pleased with our choice to engage innoVitro’s contractility service. The studies using human iPSC-derived cardiomyocytes were tailored to our needs to provide results comparable to already existing (in house) data and the fast execution followed by a comprehensive study report completed the service perfectly."

Nina Glaser,
Head of Early Safety Electrophysiology,
Merck Healthcare KGaA